The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas.
about
The prognostic performance of adding patient-reported outcomes to the MASCC risk index to identify low-risk febrile neutropenia patients with solid tumors and lymphomas.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The prognostic performance of ...... th solid tumors and lymphomas.
@en
The prognostic performance of ...... th solid tumors and lymphomas.
@nl
type
label
The prognostic performance of ...... th solid tumors and lymphomas.
@en
The prognostic performance of ...... th solid tumors and lymphomas.
@nl
prefLabel
The prognostic performance of ...... th solid tumors and lymphomas.
@en
The prognostic performance of ...... th solid tumors and lymphomas.
@nl
P2093
P2860
P1476
The prognostic performance of ...... th solid tumors and lymphomas.
@en
P2093
Denise Yun Ting Goh
Sreemanee Raaj Dorajoo
Xiao Jun Wang
P2860
P2888
P304
P356
10.1007/S00520-017-3696-6
P577
2017-04-11T00:00:00Z